Biochip for Raman quantitative analysis of biological samples
10365222 ยท 2019-07-30
Assignee
Inventors
Cpc classification
International classification
G01N33/543
PHYSICS
Abstract
Object: To provide a biochip for use in exhaustive analysis of a particular protein including DNA (deoxyribose nucleic acid) in a body fluid through Raman quantitative analysis. Resolving Means: Aqueous solution of metal complexes including plasmon metal selected from the group consisting of Au, Ag, Pt and Pd is supplied dropwise onto a carrier metal having an electrode potential of metal less noble than complex metal, followed by precipitation of nanometric quantum crystals from the metal complex on the carrier metal, the metal complex being so selected as to have a complex stability constant (log ) that is expressed by the following equation (I) correlating with the electrode potential E of the carrier metal:
E=(RT/|Z|.Math.F)In(.sub.i)(I)
(wherein E represents the standard electrode potential, R represents a gas constant, T represents the absolute temperature, Z represents the ion valency, and F represents the Faraday constant), the surface property of the metal complex quantum crystals on the carrier metal being subsequently adjusted in dependence on an object to be detected in the aqueous solution prior to the precipitation or after the precipitation.
Claims
1. A method of preparing a meso-crystal product comprising shaped meso-crystal of silver oxides comprising a silver oxide and a silver peroxide on a plasmon metal selected from the group consisting of Au, Ag, Pt and Pd, the method comprising: providing a carrier comprising a metal or alloy having an electrode potential less noble than that of the plasmon metal; providing a metal complex aqueous solution having a metal complex content of 500 to 2000 ppm; adding the metal complex aqueous solution on the carrier to form a quantum crystal of the metal complex; and re-crystallizing the quantum crystal into a meso-crystal comprising metal oxides by an alkali treatment in a presence of halogen ion, wherein the meso-crystal has a negative charge after the meso-crystal is recrystallized, wherein the metal complex has a complex stability constant (log ) and the carrier has an electrode potential E that is less than an electrode potential E as shown in the following equation:
E=(RT/|Z|F)ln()(1) wherein E is a potential of the metal complex in an aqueous solution, R is a gas constant, T is an absolute temperature, Z is an ion valence, and F represents a Faraday constant.
2. The method of claim 1, wherein the meso-crystal product comprises a meso-crystal of silver oxides comprising a silver oxide and a silver peroxide on a metal carrier comprising a Cu or Cu alloy and having a less noble electrode potential than that of Ag, wherein the meso-crystal product not only shows surface enhanced resonance phenomenon by irradiation of an exciting light thereon but also shows a negative charge in water.
3. The method of claim 2, wherein the meso-crystal has a negative charge after the meso-crystal is recrystallized from a quantum crystal of silver thiosulfate by an aqueous solution of sodium hypochlorite.
4. The method of claim 1, wherein the metal complex comprises a silver complex, and the silver complex is obtained by a reaction of a silver halide and a complexing agent having a complex stability constant (log ) of 8 or more, the complexing agent being selected from the group consisting of thiosulfate, thiocyanate, sulfite, thiourea, potassium iodide, thiosalicylic acid salt, thiocyanuric acid salt and combinations thereof.
5. The method of claim 1, wherein the metal complex comprises silver thiosulfate, the carrier comprises a Cu or Cu alloy, the quantum crystal is made on the carrier from the silver thiosulfate, and re-crystallization of the silver thiosulfate is carried out using an aqueous solution of sodium hypochlorite by an alkali treatment in the presence of chloride ion.
6. A method of preparing a meso-crystal product comprising a silver oxide nanocrystal comprising predominantly silver (I), (III) oxide, the method comprising: providing a metal carrier comprising Cu or Cu alloy having an electrode potential less noble than that of silver; providing a silver complex aqueous solution having a silver complex content of 500 to 2000 ppm; adding the silver complex aqueous solution on the carrier to form a quantum crystal of the silver complex; and re-crystallizing the quantum crystal of the silver complex into a meso-crystal comprising silver oxide nanocrystal comprising predominantly silver (I), (III) oxide by an alkali treatment in a presence of a halogen ion and polarity adjustment, wherein the silver complex has a complex stability constant (log ) and the carrier has an electrode potential E that is less than an electrode potential E as shown in the following equation
E=(RT/|Z|F)ln()(1) wherein E is a potential of the silver complex in an aqueous solution, R is a gas constant, T is an absolute temperature, Z is an ion valence, and F represents a Faraday constant.
7. The method of claim 6, wherein the metal complex comprises a silver complex, and the silver complex is obtained by a reaction of a silver halide and a complexing agent having a complex stability constant (log ) of 8 or more, the complexing agent being selected from the group consisting of thiosulfate, thiocyanate, sulfite, thiourea, potassium iodide, thiosalicylic acid salt, thiocyanuric acid salt and combinations thereof.
8. The method of claim 6, wherein the metal complex comprises silver thiosulfate, the carrier comprises a Cu or Cu alloy, the quantum crystal is made on the carrier from the silver thiosulfate, and re-crystallization of the silver thiosulfate is carried out using an aqueous solution of sodium hypochlorite by an alkali treatment in the presence of chloride ion.
9. The method of claim 6, wherein the meso-crystal product comprises a silver oxide nano-crystal comprising predominantly silver (I), (III) oxide on a metal carrier comprising Cu or Cu alloy and having a less noble electrode potential than that of silver.
10. The method of claim 6, wherein the meso-crystal has a negative charge after the meso-crystal is recrystallized from a quantum crystal of silver thiosulfate by an aqueous solution of sodium hypochlorite.
Description
BRIEF DESCRIPTION OF DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
DESCRIPTION OF EMBODIMENTS
(20) Hereinafter, embodiments of the present invention will be explained, referring to the attached drawings,
Example 1
(21) As shown in
(22)
(23) (Discussion on Formation of the Quantum Crystal)
(24) In case of 1000 ppm of silver thiosulfate complex in an aqueous solution, hexagonal column crystals of 100 nm more or less, are formed for the standing time of 3 minutes after dropping it onto a phosphor bronze plate, where it is confirmed that irregularities of several nm order are found on the hexagonal column quantum crystals from the SEM images (
Example 2
(25) On a substrate of silver thiosulfate quantum crystal made by using the phosphor bronze plate in Example 1, an aqueous solution of sodium hypochlorite having pH11 is dropped. After dropping of the aqueous solution, the solution is kept on the substrate and is brown off to prepare a bio-chip for SERS. On the other hand, the sera obtained from 12 cases of gastric cancer patients, the sera obtained from 12 cases of the colorectal carcinoma patients and the sera obtained from 12 cases of benign disease patients, all of them are diluted 10 times to prepare testing samples, which are subjected to a measurement of Raman spectra with irradiated with 633 nm laser light. There are observed much correlation between the degree of progress and the peak rise values as well as the peak integral value in case of gastric cancer and colon cancer. In addition, in the case of gastric cancer, the peak became to develop in the Raman spectrum after one minute of the laser irradiation, while in the case of colon cancer the peak became to develop in the Raman spectrum after 2-3 minutes after laser irradiation. Also,
(26) (Discussion on the Meso-Crystal of Silver Oxide Compound: Part 1)
(27) The quantum crystal substrate is subjected to a treatment of dropping 5% sodium hypochlorite solution thereon and the dropped solution is removed off 2 minutes later to obtain crystals having structures shown in
Na.sub.2S.sub.2O.sub.3+4NaClO+H.sub.2O.fwdarw.Na.sub.2SO.sub.4+H.sub.2SO.sub.4+4NaCl(1)
Ag.sup.++NaCl.fwdarw.AgCl+Na.sup.+(2)
Ag.sup.++3NaOCl.fwdarw.2AgCl+NaClO.sub.3+2Na.sup.+(3)
Ag.sup.++OH.fwdarw.AgOH(4)
2Ag.sup.++2OH.fwdarw.Ag.sub.2O+H.sub.2O(5)
Thus, although it is considered that silver ions and thiosulfate ions are important in the formation of meso-crystal according to the present invention by alkaline oxidation reaction in the presence of chloride ions and, although the silver oxide is formed according to a conventional reaction, it is surprisingly estimated that silver peroxide are predominantly formed from the following XPS measurement.
(28) (Discussion of the Meso-Crystal of Silver Oxide Compound: Part 2)
(29) XPS Measurement:
(30) The aqueous sodium hypochlorite was added dropwise to the quantum crystal substrate prepared as the above for 2 minutes, to make a re-crystal substrate, which is subjected to a XPS analysis (using models: ULVAC-PHI (Ltd.)/PHI5000 Versa Probe II (scanning X-ray photoelectron spectroscopy) for Ag and O by XPS measurement without etching. In addition, for comparison, Ag in the powder of silver chloride and the powder of silver oxide were measured. On the other hand, the recrystallized substrate was subjected to XPS measurement of Ag and O after etching for 5 minutes with an argon gas cluster ion gun. If the XPS measurement results of
INDUSTRIAL APPLICABILITY
(31) Thus, according to the present invention, by using the other biological sample selected from the group consisting of urea, blood, blood plasma, blood serum, saliva, seminal fluid, human waste, cerebral fluid, tear, mucin, exhaled component and so on, it is possible not only to detect protein profiles specific to the particular diseases and provide an early stage diagnosis and information of the disease progress by simple method, but also to selectively trap each of disease related substances, the judgement of each of diseases can be made by the measurement of Raman spectra.